Objectives Since the release of vaccines against COVID-19, there have been reports of vaccine-related neurologic complications. This study aimed to create a descriptive systematic review of movement disorders associated with COVID-19 vaccines.
Methods We described the demographics, clinical presentation, management, outcomes, and proposed patho-mechanism. A systematic review was performed according to the PRISMA guidelines. A standardized tool was used to assess the quality of the cases.
Results We have identified 8 articles that met our inclusion criteria consisting of 10 patients who developed movement disorders after vaccination. The majority were males (n = 8), with a median age of 64.5 years. The most common movement disorder was hemichorea. The rest presented with generalized chorea with myoclonus, cervical dystonia, and akathisia. Most cases responded with immunotherapy. The standardized tool used showed that most studies have a low risk of bias.
Conclusion The reported incidence of vaccine-related movement disorders was low in occurrence based on available published cases that were found.
Clinical case studies and reporting are important to the discovery of new disorders and the advancement of medical sciences. Both clinicians and basic scientists play equally important roles leading to treatment discoveries for both cures and symptoms. In the field of movement disorders, exceptional observation of patients from clinicians is imperative, not just for phenomenology but also for the variable occurrences of these disorders, along with other signs and symptoms, throughout the day and the disease course. The Movement Disorders in Asia Task Force (TF) was formed to help enhance and promote collaboration and research on movement disorders within the region. As a start, the TF has reviewed the original studies of the movement disorders that were preliminarily described in the region. These include nine disorders that were first described in Asia: Segawa disease, PARK-Parkin, X-linked dystonia-parkinsonism, dentatorubral-pallidoluysian atrophy, Woodhouse-Sakati syndrome, benign adult familial myoclonic epilepsy, Kufor-Rakeb disease, tremulous dystonia associated with mutation of the calmodulin-binding transcription activator 2 gene, and paroxysmal kinesigenic dyskinesia. We hope that the information provided will honor the original researchers and help us learn and understand how earlier neurologists and basic scientists together discovered new disorders and made advances in the field, which impact us all to this day.
Nongenetic movement disorders are common throughout the world. The movement disorders encountered may vary depending on the prevalence of certain disorders across various geographical regions. In this paper, we review historical and more common nongenetic movement disorders in Asia. The underlying causes of these movement disorders are diverse and include, among others, nutritional deficiencies, toxic and metabolic causes, and cultural Latah syndrome, contributed by geographical, economic, and cultural differences across Asia. The industrial revolution in Japan and Korea has led to diseases related to environmental toxin poisoning, such as Minamata disease and β-fluoroethyl acetate-associated cerebellar degeneration, respectively, while religious dietary restriction in the Indian subcontinent has led to infantile tremor syndrome related to vitamin B12 deficiency. In this review, we identify the salient features and key contributing factors in the development of these disorders.
Citations
Citations to this article as recorded by
Diabetic striatopathy and other acute onset de novo movement disorders in hyperglycemia Subhankar Chatterjee, Ritwik Ghosh, Payel Biswas, Shambaditya Das, Samya Sengupta, Souvik Dubey, Biman Kanti Ray, Alak Pandit, Julián Benito-León, Rana Bhattacharjee Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(3): 102997. CrossRef
Genetic leukoencephalopathies (GLEs) are a group of white matter abnormalities with heterogeneous radiological and phenotypic features. Although these conditions have mostly been described in children, adult-onset cases are increasingly recognized owing to the widespread use of neuroimaging and advances in molecular genetic testing. The disease course is often progressive with a varied spectrum of presentations, trapping neurologists in the dilemma of differential diagnosis. Movement disorders are among the most common symptoms, and their diversity makes diagnosis challenging. In this review, we focus on adult-onset GLEs with movement disorders and offer a step-by-step diagnostic approach by clarifying the phenomenology of movement, advising investigations for acquired causes, describing the clinical and radiological clues to each disease, emphasizing the limitations of advanced molecular testing, and discussing the future application of artificial intelligence. We provide a list summarizing the leukoencephalopathies associated with different categories of movement disorders. In addition to guiding clinicians on how to narrow the list of differential diagnoses with the tools currently available, another aim of this review is to emphasize the inevitable trend toward applying advanced technology in diagnosing these difficult diseases.
Treatable ataxias are a group of ataxic disorders with specific treatments. These disorders include genetic and metabolic disorders, immune-mediated ataxic disorders, and ataxic disorders associated with infectious and parainfectious etiology, vascular causes, toxins and chemicals, and endocrinopathies. This review provides a comprehensive overview of different treatable ataxias. The major metabolic and genetic treatable ataxic disorders include ataxia with vitamin E deficiency, abetalipoproteinemia, cerebrotendinous xanthomatosis, Niemann-Pick disease type C, autosomal recessive cerebellar ataxia due to coenzyme Q10 deficiency, glucose transporter type 1 deficiency, and episodic ataxia type 2. The treatment of these disorders includes the replacement of deficient cofactors and vitamins, dietary modifications, and other specific treatments. Treatable ataxias with immune-mediated etiologies include gluten ataxia, anti-glutamic acid decarboxylase antibody-associated ataxia, steroid-responsive encephalopathy associated with autoimmune thyroiditis, Miller-Fisher syndrome, multiple sclerosis, and paraneoplastic cerebellar degeneration. Although dietary modification with a gluten-free diet is adequate in gluten ataxia, other autoimmune ataxias are managed by short-course steroids, plasma exchange, or immunomodulation. For autoimmune ataxias secondary to malignancy, treatment of tumor can reduce ataxic symptoms. Chronic alcohol consumption, antiepileptics, anticancer drugs, exposure to insecticides, heavy metals, and recreational drugs are potentially avoidable and treatable causes of ataxia. Infective and parainfectious causes of cerebellar ataxias include acute cerebellitis, postinfectious ataxia, Whipple’s disease, meningoencephalitis, and progressive multifocal leukoencephalopathy. These disorders are treated with steroids and antibiotics. Recognizing treatable disorders is of paramount importance when dealing with ataxias given that early treatment can prevent permanent neurological sequelae.
Citations
Citations to this article as recorded by
Genetic Testing of Movements Disorders: A Review of Clinical Utility Dennis Yeow, Laura I. Rudaks, Sue-Faye Siow, Ryan L. Davis, Kishore R. Kumar Tremor and Other Hyperkinetic Movements.2024;[Epub] CrossRef
Rehabilitation in ataxia Anupam Gupta, NavinB Prakash, Hafis Rahman Indian Journal of Physical Medicine & Rehabilitation.2023; 33(1): 21. CrossRef
Movement disorders are common manifestations in autoimmune-mediated encephalitis. This group of diseases is suspected to be triggered by infection or neoplasm. Certain phenotypes correlate with specific autoantibody-related neurological disorders, such as orofacial-lingual dyskinesia with N-methyl-D-aspartate receptor encephalitis and faciobrachial dystonic seizures with leucine-rich glioma-inactivated protein 1 encephalitis. Early diagnosis and treatment, especially for autoantibodies targeting neuronal surface antigens, can improve prognosis. In contrast, the presence of autoantibodies against intracellular neuronal agents warrants screening for underlying malignancy. However, early clinical diagnosis is challenging because these diseases can be misdiagnosed. In this article, we review the distinctive clinical phenotypes, magnetic resonance imaging findings, and current treatment options for autoimmune-mediated encephalitis.
Huntington’s disease (HD) has become a target of the first clinical trials for gene therapy among movement disorders with a genetic origin. More than 100 clinical trials regarding HD have been tried, but all failed, although there were some improvements limited to symptomatic support. Compared to other neurogenetic disorders, HD is known to have a single genetic target. Thus, this is an advantage and its cure is more feasible than any other movement disorder with heterogeneous genetic causes. In this review paper, the authors attempt to cover the characteristics of HD itself while providing an overview of the gene transfer methods currently being researched, and will introduce an experimental trial with a preclinical model of HD followed by an update on the ongoing clinical trials for patients with HD.
Citations
Citations to this article as recorded by
The Huntington's Disease Gene Discovery Gustavo L. Franklin, Hélio A.G. Teive, Fernando Spina Tensini, Carlos Henrique Ferreira Camargo, Nayra de Souza Carvalho de Lima, Diego de Castro de dos Santos, Alex T. Meira, Sarah J. Tabrizi Movement Disorders.2024; 39(2): 227. CrossRef
Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive Models Matthew J. Barrett, Ahmed Negida, Nitai Mukhopadhyay, Jin K. Kim, Huma Nawaz, Jefin Jose, Claudia Testa Movement Disorders.2024;[Epub] CrossRef
Exosomes for neurodegenerative diseases: diagnosis and targeted therapy Hui Tao, Bo Gao Journal of Neurology.2024;[Epub] CrossRef
Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid Jonathan B. Rosenberg, Edward K. Fung, Jonathan P. Dyke, Bishnu P. De, Howard Lou, James M. Kelly, Layla Reejhsinghani, Rodolfo J. Ricart Arbona, Dolan Sondhi, Stephen M. Kaminsky, Nathalie Cartier, Christian Hinderer, Juliette Hordeaux, James M. Wilson, Human Gene Therapy.2023;[Epub] CrossRef
CRISPR: a tool with potential for genomic reprogramming in neurological disorders Yogesh K. Dhuriya, Aijaz A. Naik Molecular Biology Reports.2023; 50(2): 1845. CrossRef
Gene therapy for selected neuromuscular and trinucleotide repeat disorders – An insight to subsume South Asia for multicenter clinical trials Nalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, Darshana Sirisena, Harsha Gunasekara, Athula Dissanayake, Sunethra Senanayake, Ajantha Keshavaraj, Yetrib Hathout, Harry W.M. Steinbusch, Chandra Mohan, Ashwin Dalal, Eric Hoffman, K.Ranil D de Silva IBRO Neuroscience Reports.2023; 14: 146. CrossRef
Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis Hannah J. Van de Roovaart, Nguyen Nguyen, Timothy D. Veenstra Pharmaceuticals.2023; 16(11): 1513. CrossRef
Bioinspired Approaches for Central Nervous System Targeted Gene Delivery Jyotish Kumar, Afroz Karim, Ummy Habiba Sweety, Hemen Sarma, Md Nurunnabi, Mahesh Narayan ACS Applied Bio Materials.2023;[Epub] CrossRef
Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington’s disease Marie Vanisova, Hana Stufkova, Michaela Kohoutova, Tereza Rakosnikova, Jana Krizova, Jiri Klempir, Irena Rysankova, Jan Roth, Jiri Zeman, Hana Hansikova Ultrastructural Pathology.2022; 46(5): 462. CrossRef
Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies Zainab Irfan, Sofia Khanam, Varnita Karmakar, Sayeed Mohammed Firdous, Bothaina Samih Ismail Abou El Khier, Ilyas Khan, Muneeb U. Rehman, Andleeb Khan Brain Sciences.2022; 12(10): 1389. CrossRef
Objective Joubert syndrome (JS) is a rare syndrome characterized by ataxia and the molar tooth sign (MTS) on imaging. The present study aims to explore the clinical and radiological features in a cohort of patients with JS.
Methods This was a retrospective chart review of patients with JS evaluated by movement disorder specialists.
Results Nine patients were included in the study. All patients had facial dysmorphism and ocular abnormalities, and 4 patients had dystonia. Ocular tilt reaction and alternate skew deviation (66%) were the most common ocular abnormalities. Horizontally aligned superior cerebellar peduncles were observed in all four patients with diffusion tensor imaging, with a lack of decussation in three. Exome sequencing performed in four patients revealed novel variants in the MKS1, CPLANE1, and PIBF1 genes.
Conclusion Facial dysmorphism, ocular abnormalities and classical imaging findings were observed in all patients with JS. Apart from ataxia, dystonia and myoclonus are other movement disorders observed in JS.
Citations
Citations to this article as recorded by
Clinical and genetic characteristics of 36 children with Joubert syndrome Yan Dong, Ke Zhang, He Yao, Tianming Jia, Jun Wang, Dengna Zhu, Falin Xu, Meiying Cheng, Shichao Zhao, Xiaoyi Shi Frontiers in Pediatrics.2023;[Epub] CrossRef
CEP104 gene may involve in the pathogenesis of a new developmental disorder other than joubert syndrome Reza Shervin Badv, Mojdeh Mahdiannasser, Maryam Rasoulinezhad, Laleh Habibi, Ali Rashidi-Nezhad Molecular Biology Reports.2022; 49(8): 7231. CrossRef
Congenital Brain Malformations: An Integrated Diagnostic Approach Bimal P. Chaudhari, Mai-Lan Ho Seminars in Pediatric Neurology.2022; 42: 100973. CrossRef
Objective There is limited literature on the knowledge, attitude, and perceptions (KAP) of botulinum toxin (BoNT) treatment among patients and caregivers. The objective of this study was to assess the KAP in patients undergoing BoNT treatment for movement disorders.
Methods One hundred patients with movement disorders from National Institute of Mental Health and Neurosciences Hospital in Bengaluru, South India, were recruited. The patients underwent demographic, clinical, and Patient Knowledge Questionnaire on Botulinum Toxin Use in Movement Disorders (PKQ-BMD)-based evaluations.
Results The mean age of patients at the time of presentation was 47.97 ± 14.19 years (range, 12–79). Of all the patients, 26 (28%) patients were anxious, and 86% of these patients were reassured after appropriate counseling. There were 83 (89%) patients who found BoNT to be a costlier option. Education and previous Internet searches influenced positive performance in the “knowledge” domain and overall PKQ-BMD scores. The “number of injections” was also positively correlated with KAP performance.
Conclusion This study showed that knowledge and perceptions about BoNT treatment need to be further improved. Wider availability of the Internet has provided a positive impact on patients’ and carers’ KAP. Internet-based information, higher educational qualifications of the patients, and a higher number of BoNT injection sessions are the most important predictors of satisfactory KAP related to BoNT injection treatment in patients with movement disorders.
Objective Telemedicine has rapidly gained momentum in movement disorder neurology during the coronavirus disease (COVID-19) pandemic to preserve clinical care while mitigating the risks of in-person visits. We present data from the rapid implementation of virtual visits in a large, academic, movement disorder practice during the COVID-19 pandemic.
Methods We describe the strategic shift to virtual visits and retrospectively examine elements that impacted the ability to switch to telemedicine visits using historical prepandemic in-person data as a comparator, including demographics, distance driven, and diagnosis distribution, with an additional focus on patients with deep brain stimulators.
Results A total of 686 telemedicine visits were performed over a five-week period (60% of those previously scheduled for in-office visits). The average age of participants was 65 years, 45% were female, and 73% were Caucasian. Men were more likely to make the transition (p = 0.02). Telemedicine patients lived farther from the clinic than those seen in person (66.47 km vs. 42.16 km, p < 0.001), age was not associated with making the switch, and patient satisfaction did not change. There was a significant shift in the distribution of movement disorder diagnoses seen by telemedicine compared to prepandemic in-person visits (p < 0.001). Patients with deep brain stimulators were more likely to use telemedicine (11.5% vs. 7%, p < 0.001).
Conclusion Telemedicine is feasible, viable and relevant in the care of movement disorder patients, although health care disparities appear evident for women and minorities. Patients with deep brain stimulators preferred telemedicine in our study. Further study is warranted to explore these findings.
Citations
Citations to this article as recorded by
The Importance of Digital Health Literacy in an Evolving Parkinson’s Disease Care System Christine D. Esper, Blanca Y. Valdovinos, Ruth B. Schneider Journal of Parkinson's Disease.2024; : 1. CrossRef
Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives Andreas Wolfgang Wolff, Bernhard Haller, Antonia Franziska Demleitner, Dominik Pürner, Johanna Niederschweiberer, Isabell Cordts, Erica Westenberg, Paul Lingor Movement Disorders Clinical Practice.2023; 10(5): 819. CrossRef
Telemedicine technologies and applications in the era of COVID-19 pandemic: A systematic review Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Mohammad Heydari, Amirali Karimi, Abdollah Mahdavi, Mehrnaz Mashoufi, Arezoo Sarmad, Peyman Mirghaderi, Ahmadreza Shamsabadi, Kowsar Qaderi, Pegah Mirzapour, Amirata Fakhfouri, Hadiseh Azadi Cheshmekabodi, Kimia Health Informatics Journal.2023; 29(2): 146045822311674. CrossRef
Racial disparities in access to DBS: results of a real-world U.S. claims data analysis Michael Frassica, Drew S. Kern, Mitra Afshari, Allison T. Connolly, Chengyuan Wu, Nathan Rowland, Juan Ramirez-Castaneda, Mwiza Ushe, Claudia Salazar, Xenos Mason Frontiers in Neurology.2023;[Epub] CrossRef
Interest and Satisfaction of Telemedicine Use Among Ambulatory Neurology Patients in Western North Carolina During the COVID-19 Pandemic K. Alexander Soltany, Reyna Segovia Molina, Carly Pappo, Sharon Thomson, Kelly Pring, Siobhan Cox, Rebecca Merrill, Emily Fishman, Alexander Ambrosini, Gabby Bognet, Kristen Dodenhoff, Heidi Munger Clary, Lauren Strauss, Rachel Graham, Amy K. Guzik, Roy E Telemedicine and e-Health.2023;[Epub] CrossRef
Parkinson’s disease patients’ perspective on telephone visits during the COVID-19 pandemic Marta Magriço, Miguel Serôdio, Rita Ventura, Paulo Bugalho Journal of Neural Transmission.2023; 130(12): 1547. CrossRef
Telemedicine in Neurology: A Scoping Review of Key Outcomes in Movement Disorders Emily Houston, Amanda G. Kennedy, Donna O'Malley, Terry Rabinowitz, Gail L. Rose, James Boyd Telemedicine and e-Health.2022; 28(3): 295. CrossRef
Clinician and patient experience of neurology telephone consultations during the COVID-19 pandemic Tagore Nakornchai, Elena Conci, Anke Hensiek, J William L Brown Postgraduate Medical Journal.2022; 98(1161): 533. CrossRef
Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research B. Y. Valdovinos, J. S. Modica, R. B. Schneider Current Neurology and Neuroscience Reports.2022; 22(2): 113. CrossRef
Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic Shadi Ghourchian, Yasar A. Torres-Yaghi, Stuart H. Isaacson, Fernando Pagan, Kelly E. Lyons, Brian James Nagle, Sanskruti Patel, Rajesh Pahwa Telemedicine and e-Health.2022; 28(11): 1651. CrossRef
Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study Yaqian Xu, Megan P. Feeney, Matthew Surface, Dan Novak, Michelle S. Troche, James C. Beck, Roy N. Alcalay Movement Disorders.2022; 37(6): 1289. CrossRef
Service process factors affecting patients’ and clinicians’ experiences on rapid teleconsultation implementation in out-patient neurology services during COVID-19 pandemic: a scoping review Guangxia Meng, Carrie McAiney, Christopher M. Perlman, Ian McKillop, Therese Tisseverasinghe, Helen H. Chen BMC Health Services Research.2022;[Epub] CrossRef
Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives Esther Cubo, Pedro David Delgado-López Brain Sciences.2022; 12(12): 1735. CrossRef
Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey Rimal Bera, Morgan Bron, Betsy Benning, Samantha Cicero, Heintje Calara, Diane Darling, Ericha Franey, Kendra Martello, Charles Yonan Neuropsychiatric Disease and Treatment.2022; Volume 18: 2945. CrossRef
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of the drug. We present a case of a 38-year-old male who was started on HCQ for COVID-19 pneumonia. He was referred for evaluation of myoclonus of all extremities, which resolved after discontinuation of HCQ. The involuntary movements were first reported after the initiation of HCQ, persisted despite improvement in inflammatory and radiologic parameters and eventually resolved after HCQ discontinuation. This supports a possible causality related to adverse drug reactions from HCQ that have not been commonly reported.
Citations
Citations to this article as recorded by
Safety profile of COVID-19 drugs in a real clinical setting Mei Nee Chiu, Maitry Bhardwaj, Sangeeta Pilkhwal Sah European Journal of Clinical Pharmacology.2022; 78(5): 733. CrossRef
Eventos adversos no sistema nervoso central potencialmente relacionados aos medicamentos utilizados na COVID-19: revisão de escopo Vinícius de Mello, Vinícius de Paula Pereira, João Paulo Vilela Rodrigues, Suelem Tavares da Silva Penteado, Leonardo Régis Leira Pereira, Fabiana Rossi Varallo Revista Panamericana de Salud Pública.2022; 46: 1. CrossRef
Objective Spontaneous motor tempo (SMT), observed in walking, tapping and clapping, tends to occur around 2 Hz. Initiating and controlling movement can be difficult for people with Parkinson’s (PWP), but studies have not identified whether PWP differ from controls in SMT. For community-based interventions, e.g. dancing, it would be helpful to know a baseline SMT to optimize the tempi of cued activities. Therefore, this study compared finger tapping (FT), toe tapping (TT) and stepping ‘on the spot’ (SS) in PWP and two groups of healthy controls [age-matched controls (AMC) and young healthy controls (YHC)], as SMT is known to change with age.
Methods Participants (PWP; n = 30, AMC; n = 23, YHC; n = 35) were asked to tap or step on the spot at a natural pace for two trials lasting 40 seconds. The central 30 seconds were averaged for analyses using mean inter-onset intervals (IOI) and coefficient of variation (CoV) to measure rate and variability respectively.
Results PWP had faster SMT than both control groups, depending on the movement modality: FT, F(2, 87) = 7.92, p < 0.01 (PWP faster than YHC); TT, F(2, 87) = 4.89, p = 0.01 (PWP faster than AMC); and SS, F(2, 77) = 3.26, p = 0.04 (PWP faster than AMC). PWP had higher CoV (more variable tapping) than AMC in FT only, F(2, 87) = 4.10, p = 0.02.
Conclusion This study provides the first direct comparison of SMT between PWP and two control groups for different types of movements. Results suggest SMT is generally faster in PWP than control groups, and more variable when measured with finger tapping compared to stepping on the spot.
Citations
Citations to this article as recorded by
Synchronization during Improvised Active Music Therapy in clients with Parkinson’s disease Demian Kogutek, Emily Ready, Jeffrey D. Holmes, Jessica A. Grahn Nordic Journal of Music Therapy.2023; 32(3): 202. CrossRef
Clinical utility of paced finger tapping assessment in idiopathic normal pressure hydrocephalus Yoko Shimizu, Motoki Tanikawa, Mitsuya Horiba, Kento Sahashi, Shoji Kawashima, Akihiko Kandori, Tomoyasu Yamanaka, Yusuke Nishikawa, Noriyuki Matsukawa, Yoshino Ueki, Mitsuhito Mase Frontiers in Human Neuroscience.2023;[Epub] CrossRef
Unleashing the potential of dance: a neuroplasticity-based approach bridging from older adults to Parkinson’s disease patients Cécil J. W. Meulenberg, Kathrin Rehfeld, Saša Jovanović, Uros Marusic Frontiers in Aging Neuroscience.2023;[Epub] CrossRef
Comparison of auditory cueing in toe tapping and gait in persons with Parkinson’s disease Elizabeth L. Stegemöller, Riley Berg, Alison Warnecke, Mollie Hammer Frontiers in Human Neuroscience.2023;[Epub] CrossRef
Which factors modulate spontaneous motor tempo? A systematic review of the literature Anaïs Desbernats, Elodie Martin, Jessica Tallet Frontiers in Psychology.2023;[Epub] CrossRef
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease Manuel Bange, Gabriel Gonzalez-Escamilla, Tabea Marquardt, Angela Radetz, Christian Dresel, Damian Herz, Wolfgang Immanuel Schöllhorn, Sergiu Groppa, Muthuraman Muthuraman Journal of Parkinson's Disease.2022; 12(1): 381. CrossRef
Memory-Paced Tapping to Auditory Rhythms: Effects of Rate, Speech, and Motor Engagement Anat Kliger Amrani, Elana Zion Golumbic Journal of Speech, Language, and Hearing Research.2022; 65(3): 923. CrossRef
Virtual Reality to Evaluate the Impact of Colorful Interventions and Nature Elements on Spontaneous Walking, Gaze, and Emotion Adamantia Batistatou, Florentin Vandeville, Yvonne N. Delevoye-Turrell Frontiers in Virtual Reality.2022;[Epub] CrossRef
Neural synchronization is strongest to the spectral flux of slow music and depends on familiarity and beat salience Kristin Weineck, Olivia Xin Wen, Molly J Henry eLife.2022;[Epub] CrossRef
Spontaneous motor tempo contributes to preferred music tempo regardless of music familiarity Kyoko Hine, Koki Abe, Yuya Kinzuka, Mohammad Shehata, Katsunobu Hatano, Toshie Matsui, Shigeki Nakauchi Frontiers in Psychology.2022;[Epub] CrossRef
A general procedure to measure the pacing of body movements timed to music and metronome in younger and older adults Dawn Rose, Laurent Ott, Ségolène M. R. Guérin, Lucy E. Annett, Peter Lovatt, Yvonne N. Delevoye-Turrell Scientific Reports.2021;[Epub] CrossRef
Synchronization and locking in oscillators with flexible periods Mariya Savinov, David Swigon, Bard Ermentrout Chaos: An Interdisciplinary Journal of Nonlinear Science.2021;[Epub] CrossRef
Hierarchical control as a shared neurocognitive mechanism for language and music Rie Asano, Cedric Boeckx, Uwe Seifert Cognition.2021; 216: 104847. CrossRef
Spontaneous and stimulus-driven rhythmic behaviors in ADHD adults and controls Anat Kliger Amrani, Elana Zion Golumbic Neuropsychologia.2020; 146: 107544. CrossRef
Abnormal eye movements are commonly observed in movement disorders. Ocular motility examination should include bedside evaluation and laboratory recording of ocular misalignment, involuntary eye movements, including nystagmus and saccadic intrusions/oscillations, triggered nystagmus, saccades, smooth pursuit (SP), and the vestibulo-ocular reflex. Patients with Parkinson’s disease (PD) mostly show hypometric saccades, especially for the selfpaced saccades, and impaired SP. Early vertical saccadic palsy is characteristic of progressive supranuclear palsy-Richardson’s syndrome. Patients with cortico-basal syndrome typically show a delayed onset of saccades. Downbeat and gaze-evoked nystagmus and hypermetric saccades are characteristic ocular motor findings in ataxic disorders due to cerebellar dysfunction. In this review, we discuss various ocular motor findings in movement disorders, including PD and related disorders, ataxic syndromes, and hyperkinetic movement disorders. Systemic evaluation of the ocular motor functions may provide valuable information for early detection and monitoring of movement disorders, despite an overlap in the abnormal eye movements among different movement disorders.
Citations
Citations to this article as recorded by
The semicircular canal function is preserved with little impact on falls in patients with mild Parkinson's disease Jun-Pyo Hong, Hanim Kwon, Euyhyun Park, Sun-Uk Lee, Chan-Nyoung Lee, Byung-Jo Kim, Ji-Soo Kim, Kun-Woo Park Parkinsonism & Related Disorders.2024; 118: 105933. CrossRef
Abnormal Ocular Movement in the Early Stage of Multiple-System Atrophy With Predominant Parkinsonism Distinct From Parkinson’s Disease Hong Zhou, Luhua Wei, Yanyan Jiang, Xia Wang, Yunchuang Sun, Fan Li, Jing Chen, Wei Sun, Lin Zhang, Guiping Zhao, Zhaoxia Wang Journal of Clinical Neurology.2024; 20(1): 37. CrossRef
Smartphone video nystagmography using convolutional neural networks: ConVNG Maximilian U. Friedrich, Erich Schneider, Miriam Buerklein, Johannes Taeger, Johannes Hartig, Jens Volkmann, Robert Peach, Daniel Zeller Journal of Neurology.2023; 270(5): 2518. CrossRef
Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study C. Painous, S. Pascual-Diaz, E. Muñoz-Moreno, V. Sánchez, JC. Pariente, A. Prats-Galino, M. Soto, M. Fernández, A. Pérez-Soriano, A. Camara, E. Muñoz, F. Valldeoriola, N. Caballol, C. Pont-Sunyer, N. Martin, M. Basora, M. Tio, J. Rios, MJ. Martí, N. Barga European Radiology.2023; 33(7): 4540. CrossRef
Saw-tooth vertical saccades in progressive supranuclear palsy Min-Ku Kim, Dongje Lee, Xu Yang, Hyo-Jung Kim, Jeong‑Yoon Choi, Ji-Soo Kim Journal of Neurology.2023; 270(7): 3644. CrossRef
Non-Verbal Social Skills Assessment in Rett Syndrome: a Systematic Review Xin-yan Zhang, Karen Spruyt Review Journal of Autism and Developmental Disorders.2023;[Epub] CrossRef
Spinocerebellar ataxia type 14 (SCA14) in an Argentinian family: a case report Niharika Duggirala, Kathie J. Ngo, Sabrina M. Pagnoni, Alberto L. Rosa, Brent L. Fogel Journal of Medical Case Reports.2023;[Epub] CrossRef
Abnormal eye movements in Parkinson's disease: From experimental study to clinical application Han Li, Xue Zhang, Yong Yang, Anmu Xie Parkinsonism & Related Disorders.2023; 115: 105791. CrossRef
Oculomotor Abnormalities in a Sheep (Ovis aries) Model of Huntington’s Disease: Towards a Biomarker for Assessing Therapeutic Efficacy Sebastian D. McBride, Jan Ober, Jacek Dylak, William Schneider, A. Jennifer Morton Journal of Huntington's Disease.2023; 12(3): 189. CrossRef
Head-impulse tests aid in differentiation of multiple system atrophy from Parkinson’s disease Jae-Gyum Kim, Sung-Hwan Kim, Sun-Uk Lee, Chan-Nyoung Lee, Byung-Jo Kim, Ji-Soo Kim, Kun-Woo Park Journal of Neurology.2022; 269(6): 2972. CrossRef
Overt Oculomotor Behavior Reveals Covert Temporal Predictions Alessandro Tavano, Sonja A. Kotz Frontiers in Human Neuroscience.2022;[Epub] CrossRef
Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy Mahboubeh Habibi, Wolfgang H. Oertel, Brian J. White, Donald C. Brien, Brian C. Coe, Heidi C. Riek, Julia Perkins, Rachel Yep, Laurent Itti, Lars Timmermann, Christoph Best, Elisabeth Sittig, Annette Janzen, Douglas P. Munoz Journal of Neurology.2022; 269(9): 4920. CrossRef
A Case of AOA2 With Compound Heterozygous SETX Mutations Hee Jin Chang, Ryul Kim, Minchae Kim, Jangsup Moon, Man Jin Kim, Han-Joon Kim Journal of Movement Disorders.2022; 15(2): 178. CrossRef
Reading Warm-Up, Reading Skill, and Reading Prosody When Reading the My Grandfather Passage: An Exploratory Study Born Out of the Motor Planning Theory of Prosody and Reading Prosody Research Frank Boutsen, Eunsun Park, Justin D. Dvorak Journal of Speech, Language, and Hearing Research.2022; 65(6): 2047. CrossRef
Eye movement abnormalities in neurodegenerative langerhans cell histiocytosis Lila Autier, Bertrand Gaymard, Eléonore Bayen, Antoine Del Cul, Fleur Cohen-Aubart, Nadine Martin-Duverneuil, Julien Haroche, Karima Mokhtari, Sébastien Héritier, Jean Donadieu, Khê Hoang-Xuan, Ahmed Idbaih Neurological Sciences.2022; 43(11): 6539. CrossRef
Multiple step saccades in simply reactive saccades could serve as a complementary biomarker for the early diagnosis of Parkinson’s disease Wenbo Ma, Min Li, Junru Wu, Zhihao Zhang, Fangfang Jia, Mingsha Zhang, Hagai Bergman, Xuemei Li, Zhipei Ling, Xin Xu Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
The effects of age and sex on the incidence of multiple step saccades and corrective saccades Wenbo Ma, Mingsha Zhang Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Oculomotor impairments in de novo Parkinson’s disease Meng-Xi Zhou, Qin Wang, Yin Lin, Qian Xu, Li Wu, Ya-Jing Chen, Yu-Han Jiang, Qing He, Lei Zhao, You-Rong Dong, Jian-Ren Liu, Wei Chen Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson’s disease JianYuan Zhang, Bin Zhang, QingGuo Ren, Qing Zhong, Ye Li, GuoTao Liu, XiaoTian Ma, CuiPing Zhao Neurological Sciences.2021; 42(6): 2337. CrossRef
Abnormalities of smooth pursuit in Parkinson’s disease: A systematic review Karen Frei Clinical Parkinsonism & Related Disorders.2021; 4: 100085. CrossRef
Central nystagmus in progressive supranuclear palsy: A neglected clinical feature? Maja Klarendic, Manja Hribar, Nina Bozanic Urbancic, Nina Zupancic, Milica G. Kramberger, Maja Trost, Saba Battelino, Diego Kaski, Maja Kojovic Parkinsonism & Related Disorders.2021; 84: 15. CrossRef
Analysis of vertical eye movements in Parkinson’s disease and its potential for diagnosis Sajjad Farashi Applied Intelligence.2021; 51(11): 8260. CrossRef
Abnormal eye movements in parkinsonism: a historical view Tereza Ko, Augusto Mädke Brenner, Nicholas Pili Monteiro, Mariana Severo Debastiani, Alberto Chitolina Nesello, Arlete Hilbig Arquivos de Neuro-Psiquiatria.2021; 79(5): 457. CrossRef
Morphological classification and changes in dementia (Review) Alexandra Tudor, Antonia Vasile, Simona Trifu, Mihai Cristea Experimental and Therapeutic Medicine.2021;[Epub] CrossRef
BCAP31-related syndrome: The first de novo report Berardo Rinaldi, Evelien Van Hoof, Anniek Corveleyn, Annick Van Cauter, Thomy de Ravel European Journal of Medical Genetics.2020; 63(2): 103732. CrossRef
Hypomania and saccadic changes in Parkinson’s disease: influence of D2 and D3 dopaminergic signalling Esther A. Pelzer, Barbara Dillenburger, Sophie Grundmann, Vladimir Iliaev, Sophie Aschenberg, Corina Melzer, Martin Hess, Gereon R. Fink, Carsten Eggers, Marc Tittgemeyer, Lars Timmermann npj Parkinson's Disease.2020;[Epub] CrossRef
Management of Visual Dysfunction in Patients with Parkinson’s Disease Joseph Savitt, Rachid Aouchiche, Bastiaan R. Bloem, Patrik Brundin Journal of Parkinson's Disease.2020; 10(s1): S49. CrossRef
Ocular motor manifestations of movement disorders Grace F. Crotty, Bart K. Chwalisz Current Opinion in Ophthalmology.2019; 30(6): 443. CrossRef
Objective Neurological symptoms in hospitalized patients are not rare, and neurological consultation for movement disorders is especially important in evaluating or managing those with various movement disorders. Therefore, we investigated a clinical pattern of in-hospital consultations for various movement disorders in a tertiary care university hospital.
Methods Over two years, a total of 202 patients (70.7 ± 11.8 years of age) presenting with movement disorders referred to movement disorder specialists were investigated.
Results The main symptoms referred by nonneurologists were tremor (56.9%), parkinsonism (16.8%), and gait disturbance (8.9%). The most frequent diagnostic category was toxic/metabolic-caused movement disorder (T/MCMD) (35%) with regard to medications, followed by Parkinson’s disease (PD) (16%). Regarding the mode of onset, T/MCMD was the leading cause for acute (68%) and subacute onset (46%), while PD was the leading disorder (31%) for chronic onset.
Conclusion The current study showed a characteristic pattern of inpatients presenting with movement disorders. Furthermore, our findings highlighted the clinical significance of drug use or metabolic problems for treating this patient population.
Citations
Citations to this article as recorded by
Pattern and frequency of involuntary movements: hospital-based study H. N. El Tallawy, A. S. Shalash, M. A. Abdelhamed, R. E. Elsabrout The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2023;[Epub] CrossRef
Clinical Spectrum of Movement Disorders in Neurology Inpatients in a Tertiary Care Centre Shabeer Ahmad Paul, Gouranga Prasad Mondal, Ramesh Bhattacharyya, Kartik Chandra Ghosh, Sarbajit Das, Suman Das, Hema Krishna, Chandrakanta Patra Journal of Neurosciences in Rural Practice.2021; 12: 581. CrossRef
Objective
To report demographic data from a large cohort of patients with oromandibular dystonia (OMD).
Methods
This is a retrospective review of patients with OMD referred to our institution between 1989 and 2015. Demographic (age of onset, gender, and familial history of dystonia) and clinical (type of OMD, associated dystonia, and etiology of dystonia) data were collected from a cohort of 240 individuals.
Results
The mean age of onset of OMD was 51.6 years old, with a female predominance (2:1). A family history of dystonia was found in 6 patients (2.5%). One hundred and forty-nine patients (62.1%) had the jaw-opening type of OMD, 48 patients (20.0%) had the jaw-closing type, and 43 patients (17.9%) had a mixed form of OMD. Lingual dystonia was also present in 64 (26.7%) of these patients. Eighty-two patients (34.2%) had a focal dystonia, 131 patients (54.6%) had a segmental dystonia, and 27 patients (11.3%) had a generalized dystonia. One hundred and seventy-one patients (71.3%) had idiopathic OMD.
Conclusion
OMD is a chronic and disabling focal dystonia. Our study found a prevalence of female patients, an onset in middle age and a predominantly idiopathic etiology. Unlike other studies, jaw-opening was found to be the most frequent clinical type of OMD.
Citations
Citations to this article as recorded by
Surface electromyography for evaluating patients with oromandibular dystonia Jae-Hyung Kim, Byung-Gook Kim, Yeong-Gwan Im CRANIO®.2024; 42(3): 316. CrossRef
Tongue dystonia as CIS and presenting symptom of multiple sclerosis Farid Shamlou, Narges Ebrahimi, Ahmad Chitsaz Neuroimmunology Reports.2024; 5: 100191. CrossRef
Oromandibular dystonia: from onset to spread a multicenter italian study Assunta Trinchillo, Marcello Esposito, Carmen Terranova, Vincenzo Rizzo, Giovanni Fabbrini, Gina Ferrazzano, Daniele Belvisi, Roberto Erro, Paolo Barone, Francesco Bono, Francesca Di Biasio, Anna Rita Bentivoglio, Christian Lettieri, Maria Concetta Altavi Neurological Sciences.2024;[Epub] CrossRef
Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients Mehmet Balal, Meltem Demirkiran Tremor and Other Hyperkinetic Movements.2023;[Epub] CrossRef
Oromandibular Dystonia is a Prominent Feature in Patients with Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Helio van der Linden Jr., Christiane Cobas, Andre Felipe Pinto Duarte, Marcelo Rodrigues Masruha Journal of Inborn Errors of Metabolism and Screening.2023;[Epub] CrossRef
Clinical Presentation and Management of Peripheral-induced Oromandibular Dystonia in Nigeria: A Case Report and Literature Update Nonso Emmanuel Onyia, Mercy Okoh, Obinna Francis Igwilo, Izegboya Vivian Ukpebor, Eze Stephen Nwauzor Nigerian Journal of Medicine.2023; 32(4): 433. CrossRef
Oromandibular dystonia – A systematic review Udit Saraf, Mitesh Chandarana, KP Divya, Syam Krishnan Annals of Indian Academy of Neurology.2022; 25(1): 26. CrossRef
Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System Kazuya Yoshida Toxins.2022; 14(4): 282. CrossRef
Botulinum toxin injections in jaw-opening dystonia. The lateral pterygoid – maxillary artery problem Sena Ünal, F. Tugra Karaarslan-Turk, Muhittin Cenk Akbostanci, Elif Peker, Rezzak Yilmaz Journal of Clinical Neuroscience.2022; 101: 217. CrossRef
Oromandibular dystonia seen during pramipexole treatment: A rare case Fatma KARA, Mehmet Fatih GÖL, Ayhan VARLIBAŞ Journal of Surgery and Medicine.2022; 6(6): 1. CrossRef
Dystonia, chorea, hemiballismus and other dyskinesias Matteo Bologna, Josep Valls-Solè, Nitish Kamble, Pramod Kumar Pal, Antonella Conte, Andrea Guerra, Daniele Belvisi, Alfredo Berardelli Clinical Neurophysiology.2022; 140: 110. CrossRef
Movement disorders of the mouth: a review of the common phenomenologies C. M. Ghadery, L. V. Kalia, B. S. Connolly Journal of Neurology.2022; 269(11): 5812. CrossRef
Botulinum Toxin in Movement Disorders: An Update Charenya Anandan, Joseph Jankovic Toxins.2021; 13(1): 42. CrossRef
Temporomandibular disorder–related characteristics and treatment outcomes in Oromandibular Dystonia patients in two different clinical settings: A cross‐sectional study Asha Sude, Joseph Matsumoto, Shanti Kaimal, Ashley Petersen, Donald R. Nixdorf Journal of Oral Rehabilitation.2021; 48(5): 542. CrossRef
Jaw Pain and Oromandibular Dysfunction After a Complex Hospital Course Sarah Smith, Ny-Ying Lam American Journal of Physical Medicine & Rehabilitation.2021; 100(5): e62. CrossRef
Oromandibular Dystonia: A Clinical Examination of 2,020 Cases Laura M. Scorr, Stewart A. Factor, Sahyli Perez Parra, Rachel Kaye, Randal C. Paniello, Scott A. Norris, Joel S. Perlmutter, Tobias Bäumer, Tatiana Usnich, Brian D. Berman, Marie Mailly, Emmanuel Roze, Marie Vidailhet, Joseph Jankovic, Mark S. LeDoux, Ric Frontiers in Neurology.2021;[Epub] CrossRef
Evaluation of Treatment Outcomes in Oromandibular Dystonia Using Surface Electromyography: A Case Series Yeong-Gwan Im, Jae-Hyung Kim, Byung-Gook Kim Journal of Oral Medicine and Pain.2021; 46(4): 143. CrossRef
Application of botulinum toxin in pregnancy and its impact on female reproductive health Wu Li, Min Tang Expert Opinion on Drug Safety.2020; 19(1): 83. CrossRef
Prevalence and clinical characteristics of patients with oromandibular dystonia seen in the orofacial pain clinic: a retrospective study Asha Sude, Donald R. Nixdorf Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2020; 130(2): 169. CrossRef
Clinical spectrum of focal dystonias: Experience from a tertiary care center Rupesh Prasad, Deepika Joshi, VijayN Mishra, RameshwarN Chaurasia, Abhishek Pathak Annals of Movement Disorders.2020; 3(2): 99. CrossRef
Bite injury related to oromandibular dystonia extending to the maxillary sinus: A case report Yoshiro Koma, Takehiro Fujimoto, Shinji Uejima, Kotaro Sato, Keisuke Sugimoto, Satoshi Yamaguchi, Jun Ishikawa, Kazuya Nambu, Hideharu Hibi Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2020; 32(6): 503. CrossRef
Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis Pariessa D. Dadgardoust, Raymond L. Rosales, Ria Monica Asuncion, Dirk Dressler Journal of Neural Transmission.2019; 126(2): 141. CrossRef
Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features Kazuya Yoshida Toxins.2019; 11(1): 51. CrossRef
Oromandibular dystonia, mental distress and oro‐facial dysfunction—A follow‐up 8‐10 years after start of treatment with botulinum toxin Merete Bakke, Sara Baram, Torben Dalager, Heidi Bryde Biernat, Eigild Møller Journal of Oral Rehabilitation.2019; 46(5): 441. CrossRef
Pseudodystonia: A new perspective on an old phenomenon Rok Berlot, Kailash P. Bhatia, Maja Kojović Parkinsonism & Related Disorders.2019; 62: 44. CrossRef
Severe Jaw‐Opening Dystonia as an Unusual Manifestation of Levodopa‐Related Wearing‐Off in Parkinson's Disease, and Successful Treatment With Botulinum Toxin Injection Pankaj Ashok Agarwal Movement Disorders Clinical Practice.2019; 6(6): 500. CrossRef